Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

After clearing out heart disease drug, Arrowhead maps out obesity development plans
Fierce Biotech
Wednesday, August 14, 2024 - 10:41pm
tags:
Arrowhead Pharmaceuticals, RNAi, R&D, obesity, heart disease
FDA approves Incyte's treatment for chronic graft-versus-host disease
Reuters
Wednesday, August 14, 2024 - 10:37pm
tags:
Incyte, FDA, graft vs host disease, Niktimvo
FDA approves Gilead's seladelpar for primary biliary cholangitis
First Word Pharma
Wednesday, August 14, 2024 - 10:35pm
tags:
Gilead Sciences, seladelpar, Livdelzi, liver disease, primary biliary cholangitis
WHO declares mpox outbreaks in Africa a global health emergency as a new form of the virus spreads
AP News
Wednesday, August 14, 2024 - 10:32pm
tags:
WHO, mpox, Africa
Bluebird stock plummets 18% with slow uptake of sickle cell disease gene therapy Lyfgenia
Fierce Pharma
Wednesday, August 14, 2024 - 10:31pm
tags:
Bluebird Bio, sickle cell disease, Vertex Pharmaceuticals, Lyfgenia, Casgevy
J&J and Roche are the strongest companies in the biopharma industry, says S&P Global
Fierce Pharma
Wednesday, August 14, 2024 - 11:20am
tags:
S&P Global, JNJ, Roche
Astellas' gastric cancer therapy gets UK regulator's nod
Reuters
Wednesday, August 14, 2024 - 11:19am
tags:
Astellas, UK, gastric cancer, monoclonal antibodies, Vyloy
Viracta lays off 23% of staff, pauses program to slim down for race to finish line in lymphoma
Fierce Biotech
Wednesday, August 14, 2024 - 11:18am
tags:
Viracta Therapeutics, layoffs, solid tumors, valganciclovir, peripheral T-cell lymphoma
Evotec, citing research spending slowdown, cuts jobs and exits gene therapy
BioPharma Dive
Wednesday, August 14, 2024 - 11:09am
tags:
Evotec, CDMO, layoffs, restructuring
Pfizer appoints AI chief, expanding digital leadership team
BioPharma Dive
Wednesday, August 14, 2024 - 11:07am
tags:
Pfizer, artificial intelligence, digital pharma
Kezar stalls solid tumor trial to focus on autoimmune disease candidate
Pharmaceutical Technology
Wednesday, August 14, 2024 - 11:05am
tags:
Kezar Life Sciences, zetomipzomib, clinical trials, lupus, autoimmune hepatitis, solid tumors
Lexicon to lay off 50% of field force as it prioritizes heart failure drug, potential US diabetes launch
Fierce Pharma
Wednesday, August 14, 2024 - 11:03am
tags:
Lexicon Pharmaceuticals, type 1 diabetes, sotagliflozin, layoffs, restructuring
Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope.
Pharma Voice
Wednesday, August 14, 2024 - 11:02am
tags:
BioNTech, COVID-19, MRNA, oncology, cancer
What to watch when Medicare releases first negotiated drug prices
Axios
Wednesday, August 14, 2024 - 11:01am
tags:
Joe Biden, Medicare, drug pricing, Inflation Reduction Act
AI medtech specialist Firefly lists on Nasdaq after merger
Pharmaphorum
Wednesday, August 14, 2024 - 10:59am
tags:
Medtech, Firefly Neuroscience, NASDAQ, WaveDancer, artificial intelligence
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for Endometrial Cancer
BioSpace
Wednesday, August 14, 2024 - 10:58am
tags:
AstraZeneca, Europe, Imfinzi, Lynparza, endometrial cancer
Abbott’s FreeStyle Libre CGM Meets Medtronic’s Insulin Delivery
Xtalks
Tuesday, August 13, 2024 - 11:11pm
tags:
Abbott Labs, Medtronic, Medtech, diabetes, CGMs, insulin
Investor activism resurfaces at Aurinia after CEO’s board role, exec pay lost majority support
Fierce Pharma
Tuesday, August 13, 2024 - 11:10pm
tags:
Aurinia, Robert Foster, activist investors
Amgen sues Samsung biotech unit over bone drug copies
Reuters
Tuesday, August 13, 2024 - 11:08pm
tags:
Amgen, Samsung, biologics, biosimilars, legal, Prolia, Xgeva
Acelyrin shifts from main drug, lays off staff
BioPharma Dive
Tuesday, August 13, 2024 - 11:03pm
tags:
Acelyrin, layoffs, izokibep, lonigutamab, thyroid eye disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.